NO20030081L - Anvendelse av stammer fra parapoxvirus mot organfibroser - Google Patents
Anvendelse av stammer fra parapoxvirus mot organfibroserInfo
- Publication number
- NO20030081L NO20030081L NO20030081A NO20030081A NO20030081L NO 20030081 L NO20030081 L NO 20030081L NO 20030081 A NO20030081 A NO 20030081A NO 20030081 A NO20030081 A NO 20030081A NO 20030081 L NO20030081 L NO 20030081L
- Authority
- NO
- Norway
- Prior art keywords
- organ fibrosis
- strains against
- against organ
- parapoxvirus
- parapoxvirus strains
- Prior art date
Links
- 241000700639 Parapoxvirus Species 0.000 title abstract 2
- 206010016654 Fibrosis Diseases 0.000 title 1
- 230000004761 fibrosis Effects 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
- 102000008186 Collagen Human genes 0.000 abstract 1
- 108010035532 Collagen Proteins 0.000 abstract 1
- 229920001436 collagen Polymers 0.000 abstract 1
- 230000008021 deposition Effects 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000004185 liver Anatomy 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
- 210000001835 viscera Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/76—Viruses; Subviral particles; Bacteriophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24211—Parapoxvirus, e.g. Orf virus
- C12N2710/24232—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Virology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Addiction (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Psychiatry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10033581 | 2000-07-11 | ||
| DE10122233A DE10122233A1 (de) | 2000-07-11 | 2001-05-08 | Verwendung von Stämmen des Parapoxvirus ovis gegen Organfibrosen |
| PCT/EP2001/007978 WO2002004019A2 (de) | 2000-07-11 | 2001-07-11 | Verwendung von stämmen des parapoxvirus ovis gegen organfibrosen |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20030081D0 NO20030081D0 (no) | 2003-01-08 |
| NO20030081L true NO20030081L (no) | 2003-01-08 |
Family
ID=26006334
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20030081A NO20030081L (no) | 2000-07-11 | 2003-01-08 | Anvendelse av stammer fra parapoxvirus mot organfibroser |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US6632647B2 (hu) |
| EP (1) | EP1303302B1 (hu) |
| JP (1) | JP5106736B2 (hu) |
| CN (1) | CN1452496B (hu) |
| AR (1) | AR028800A1 (hu) |
| AU (2) | AU2001285827B2 (hu) |
| BG (1) | BG107447A (hu) |
| CA (1) | CA2415399C (hu) |
| CZ (1) | CZ200372A3 (hu) |
| DK (1) | DK200300014A (hu) |
| EE (1) | EE200300019A (hu) |
| FI (1) | FI20030038A (hu) |
| GB (1) | GB2383752B (hu) |
| HK (1) | HK1054330B (hu) |
| HR (1) | HRP20030097A2 (hu) |
| HU (1) | HU227668B1 (hu) |
| IL (1) | IL153826A0 (hu) |
| LT (1) | LT5064B (hu) |
| LU (1) | LU90996B1 (hu) |
| LV (1) | LV12991B (hu) |
| MA (1) | MA25765A1 (hu) |
| MX (1) | MXPA03000278A (hu) |
| NO (1) | NO20030081L (hu) |
| NZ (1) | NZ523535A (hu) |
| PL (1) | PL360839A1 (hu) |
| RU (1) | RU2003104522A (hu) |
| SE (1) | SE0300033L (hu) |
| SI (1) | SI21171A (hu) |
| SK (1) | SK382003A3 (hu) |
| WO (1) | WO2002004019A2 (hu) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
| US6752995B2 (en) | 2002-04-15 | 2004-06-22 | Board Of Regents, The University Of Texas System | Nucleic acid and polypeptide sequences useful as adjuvants |
| WO2003050135A2 (en) | 2001-12-07 | 2003-06-19 | Board Of Regents The University Of Texas System | Use a parapox b2l protein to modify immune responses to administered antigens |
| EP1574211A1 (en) | 2004-03-09 | 2005-09-14 | Inserm | Use of antagonists of the CB1 receptor for the manufacture of a composition useful for the treatment of hepatic diseases |
| WO2012045473A1 (en) * | 2010-10-07 | 2012-04-12 | Technische Universität München | Viruses for the treatment of fibrosis |
| KR20180129779A (ko) | 2016-02-16 | 2018-12-05 | 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 | 섬유화를 치료하기 위한 의약 조성물 |
| TW201919675A (zh) * | 2017-09-07 | 2019-06-01 | 德商艾庫瑞斯公司 | 使用羊副痘疹病毒(Parapoxvirus ovis；PPVO)及至少一種額外抗病毒藥之經B型肝炎病毒(HBV)感染之個體之組合療法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2714665A1 (de) * | 1977-04-01 | 1978-10-05 | Mayr Anton | Praeparat zur behandlung von herpes zoster und anderen herpes-infektionen, sowie verfahren zu seiner herstellung |
| US4360510A (en) * | 1979-11-30 | 1982-11-23 | Proctor Julian W | Method for screening anti-tumor agents of the reticulo-endothelial stimulant class |
| US4663306A (en) * | 1983-09-23 | 1987-05-05 | Ribi Immunochem Research, Inc. | Pyridine-soluble extract-refined detoxified endotoxin composition and use |
| DE3504940C2 (de) | 1984-02-17 | 1997-11-06 | Bayer Ag | Multipotente Paramunitätsmediatoren, Verfahren zu ihrer Herstellung und diese Mediatoren enthaltende Arzneimittel |
| DE3816139A1 (de) * | 1987-10-17 | 1989-04-27 | Bayer Ag | Verfahren zur herstellung von paramunitaetsinducern |
| DE4405841C1 (de) * | 1994-02-23 | 1995-01-05 | Mayr Anton Prof Dr Med Vet Dr | Multipotente Paramunitätsinducer auf der Basis von Kombinationen von Pockenviruskomponenten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| PL329353A1 (en) * | 1996-04-15 | 1999-03-29 | Anton Mayr | Novel indications for application of as a drug the agents obtained from smallpox or parapox viruses, possessing many potential ablities, capable to produce parapox immunity |
| DE19922407A1 (de) * | 1999-05-14 | 2000-11-16 | Bayer Ag | Organ-, gewebs- und zellspezifisches Immuntherapeutikum für chronische virale Infektionen, sowie entzündliche, degenerative und proliferative Erkrankungen insbesondere der Leber sowie Krebs auf der Basis von rekombinantem Parapoxvirus |
| IL139593A (en) * | 2000-11-09 | 2010-12-30 | Biogem Optical Ltd | Method for the detection of viable microorganisms |
-
2001
- 2001-07-11 LU LU90996A patent/LU90996B1/en active
- 2001-07-11 CN CN018151272A patent/CN1452496B/zh not_active Expired - Lifetime
- 2001-07-11 IL IL15382601A patent/IL153826A0/xx active IP Right Grant
- 2001-07-11 CA CA2415399A patent/CA2415399C/en not_active Expired - Lifetime
- 2001-07-11 HU HU0303830A patent/HU227668B1/hu not_active IP Right Cessation
- 2001-07-11 JP JP2002508473A patent/JP5106736B2/ja not_active Expired - Lifetime
- 2001-07-11 NZ NZ52353501A patent/NZ523535A/xx unknown
- 2001-07-11 EP EP01965110A patent/EP1303302B1/de not_active Expired - Lifetime
- 2001-07-11 US US09/903,005 patent/US6632647B2/en not_active Expired - Lifetime
- 2001-07-11 CZ CZ200372A patent/CZ200372A3/cs unknown
- 2001-07-11 SI SI200120047A patent/SI21171A/sl not_active IP Right Cessation
- 2001-07-11 GB GB0302629A patent/GB2383752B/en not_active Expired - Lifetime
- 2001-07-11 AU AU2001285827A patent/AU2001285827B2/en not_active Expired
- 2001-07-11 AU AU8582701A patent/AU8582701A/xx active Pending
- 2001-07-11 RU RU2003104522/15A patent/RU2003104522A/ru not_active Application Discontinuation
- 2001-07-11 AR ARP010103291A patent/AR028800A1/es not_active Application Discontinuation
- 2001-07-11 PL PL36083901A patent/PL360839A1/xx not_active Application Discontinuation
- 2001-07-11 EE EEP200300019A patent/EE200300019A/xx unknown
- 2001-07-11 WO PCT/EP2001/007978 patent/WO2002004019A2/de active IP Right Grant
- 2001-07-11 SK SK38-2003A patent/SK382003A3/sk not_active Application Discontinuation
- 2001-07-11 MX MXPA03000278A patent/MXPA03000278A/es active IP Right Grant
-
2003
- 2003-01-08 BG BG107447A patent/BG107447A/bg unknown
- 2003-01-08 NO NO20030081A patent/NO20030081L/no not_active Application Discontinuation
- 2003-01-10 MA MA26995A patent/MA25765A1/fr unknown
- 2003-01-10 SE SE0300033A patent/SE0300033L/xx not_active Application Discontinuation
- 2003-01-10 DK DK200300014A patent/DK200300014A/da not_active Application Discontinuation
- 2003-01-10 FI FI20030038A patent/FI20030038A/fi not_active IP Right Cessation
- 2003-02-03 LT LT2003008A patent/LT5064B/lt not_active IP Right Cessation
- 2003-02-10 HR HR20030097A patent/HRP20030097A2/xx not_active Application Discontinuation
- 2003-02-11 LV LVP-03-13A patent/LV12991B/lv unknown
- 2003-09-15 HK HK03106614.0A patent/HK1054330B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UA94390C2 (ru) | Применение производных индолинонов, предназначенных для лечения или предупреждения идиопатического фиброза легких | |
| SG149027A1 (en) | Substituted urea derivatives for treating cardiac diseases | |
| NO20064186L (no) | Substituerte pyrazolin sammensetninger for a redusere triglycerider i blod | |
| EE200400020A (et) | Asendatud oksasolidinoonid kombineeritud raviks | |
| NO20065847L (no) | Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase | |
| WO2003104273A3 (en) | THERAPEUTIC EPITOPES AND THEIR USES | |
| ATE508735T1 (de) | Pulmonale verabreichung von aminoglykosiden | |
| MXPA05007513A (es) | Compuestos, composiciones y metodos. | |
| NO952863D0 (no) | Fluoxetin-farmasöytiske sammensetninger | |
| EA200702493A1 (ru) | Соединения и способы лечения или предотвращения флавивирусных инфекций | |
| EP1605752A4 (en) | COMPOUNDS, COMPOSITIONS AND METHODS | |
| HK1109783A1 (en) | Use of cultured three-dimensional tissue for treating congestive heart failure | |
| CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
| AR074313A1 (es) | Metodo para tratar o prevenir la trombosis utilizando etexilato de dabigatran o una sal del mismo. uso. kit | |
| NZ623674A (en) | Vip fragments and methods of use | |
| ATE462424T1 (de) | Therapeutische anwendung von zerstäubtem s- nitrosoglutathion bei zystischer fibrose | |
| TN2011000227A1 (en) | Method for treating or preventing thrombosis using dabigatran etexilate or a salt thereof with improved efficacy over conventional warfarin therapy | |
| NO20056218L (no) | Substituerte pyrrolderivater og anvendelse derav som HMF-CoA reduktase-inhibitorer | |
| AR037556A1 (es) | Composicion farmaceutica que comprende un abridor del canal de c1c-2 | |
| NO20030081L (no) | Anvendelse av stammer fra parapoxvirus mot organfibroser | |
| NO20076405L (no) | Anvendelse av 24-nor-UDCA | |
| WO2003059258A3 (en) | Compositions and methods for treating heart failure | |
| EA200600374A1 (ru) | Замещённые пиперидинофенилоксазолидиноны, обладающие противомикробной активностью, с повышенной in vivo эффективностью | |
| CR9073A (es) | Coadministracion de tigeciclina y digoxin | |
| UA85232C2 (ru) | Оксабиспидиновые соединения и их применение в лечении сердечных аритмий |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |